PTGS2 and breast cancer: To determine whether the COX-2 polymorphisms have effect on the clinical features of breast cancer patients, we then analyzed the association between the COX-2 polymorphisms and a series of clinicopathologic parameters, including tumor size, lymph node metastasis, and the statuses of ER, PR and Her-2.